Table 3 Prevalence of Comorbidities in Patients who underwent Elective THA and HRA
Comorbidities (%) | THA | HRA | p |
|---|---|---|---|
Acquired immunodeficiency syndrome | 0.14 | 0.08 | 0.1684 |
Alcohol abuse | 1.54 | 1.23 | 0.0165 |
Deficiency anemias | 13.49 | 8.38 | < 0.0001 |
Arrhythmia | 3.75 | 1.01 | < 0.0001 |
Chronic blood loss anemia | 1.81 | 2.18 | 0.0077 |
Congestive heart failure | 2.37 | 0.19 | < 0.0001 |
Chronic pulmonary disease | 13.84 | 6.51 | < 0.0001 |
Coagulopathy | 2.01 | 2.04 | 0.8669 |
Depression | 10.59 | 7.29 | < 0.0001 |
Diabetes uncomplicated | 13.02 | 4.15 | < 0.0001 |
Diabetes with chronic complications | 1.11 | 0.19 | < 0.0001 |
Drug abuse | 0.67 | 0.61 | 0.4825 |
Hypertension | 58.8 | 30.41 | < 0.0001 |
Hypothyroidism | 12.97 | 5.2 | < 0.0001 |
Liver disease | 0.98 | 0.67 | 0.0021 |
Lymphoma | 0.34 | 0.12 | 0.0004 |
Fluid and electrolyte disorders | 8.03 | 3.98 | < 0.0001 |
Metastatic cancer | 0.13 | 0.05 | 0.0415 |
Other neurologic disorders | 3.21 | 1.17 | < 0.0001 |
Obesity | 14.6 | 10.77 | < 0.0001 |
Paralysis | 0.32 | 0.09 | 0.0001 |
Peripheral vascular disorders | 2.16 | 0.41 | < 0.0001 |
Psychoses | 1.71 | 0.92 | < 0.0001 |
Pulmonary circulation disorders | 0.7 | 0.18 | < 0.0001 |
Renal failure | 3.5 | 0.53 | < 0.0001 |
Solid tumor without metastasis | 0.51 | 0.14 | < 0.0001 |
Peptic ulcer disease excluding bleeding | 0.02 | 0 | 0.4295 |
Valvular disease | 3.78 | 1.86 | < 0.0001 |
Weight loss | 0.38 | 0.13 | 0.0001 |